This inventor holds 1 USPTO granted patent. Top assignee: Sumitomo Pharmaceuticals Company Limited. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Hiroko Yamamoto: Innovator in Hepatitis B Therapeutics
Introduction
Hiroko Yamamoto is a prominent inventor based in Higashiosaka, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents for hepatitis B. Her innovative work has garnered attention in the scientific community.
Latest Patents
Hiroko Yamamoto holds a patent for a single-stranded antibody against the hepatitis B virus core protein. This patent includes a DNA sequence that codes for a single-stranded antibody capable of binding to the hepatitis B virus core protein. Additionally, it encompasses a therapeutic agent for hepatitis B that comprises this single-stranded antibody as the active ingredient, along with a gene therapeutic agent containing the DNA as the active component.
Career Highlights
Hiroko is currently employed at Sumitomo Pharmaceuticals Company Limited, where she continues to advance her research in the field of virology and therapeutics. Her work is pivotal in the ongoing fight against hepatitis B, a virus that affects millions worldwide.
Collaborations
Some of her notable coworkers include Masato Yamamoto and Norio Hayashi, who contribute to her research efforts and collaborative projects.
Conclusion
Hiroko Yamamoto's innovative contributions to hepatitis B therapeutics highlight her role as a leading inventor in the biotechnology sector. Her work not only advances scientific knowledge but also has the potential to improve patient outcomes in the treatment of hepatitis B.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile